Welcome to Oncology Newswatch's case report exploration. This interactive case report will engage your experience and knowledge about details of a given case. Along the way, we will provide details and at the end, we will share the patient's outcome.


Next-generation sequencing may help identify patients with smoldering multiple myeloma at high risk for disease progression.

A comparative effectiveness study analyzed response to anemia supportive treatment for patients with multiple myeloma or lymphoma, published in Supportive Care in Cancer (online November 7, 2017; doi:10.1007/s00520-017-3948-5).

Read More

The International Myeloma Foundation (IMF)–the oldest and largest organization dedicated to improving the lives of myeloma patients while working toward a cure–has issued a statement calling a report by the Institute for Clinical and Economic Review (ICER) on the value of myeloma drugs overly simplistic and one that could limit patient access to optimal treatments.

Read More

Combination therapy involving a novel treatment is associated with reduced risk of death and improved progression-free survival (PFS) in patients with advanced multiple myeloma, according to research presented at the 22nd Congress of the European Hematology Association (June 22-25, 2017; Madrid, Spain).


Related Content

Read More

Subscribe to Multiple Myeloma